About 700 reports

Targeting inflammation Nov ##, 2017: Short-circuiting dangerous immune cells to treat asthma Thunderstorm asthma is a type of allergic asthma that can be life threatening, affecting asthmatics and even people who don' t even know they have asthma.

  • Cancer
  • Pharmaceutical
  • Therapy
  • Australia
  • Social Conditions

In this project, the researchers will study potential mechanisms for asthma development in two biological pathways where asthma genes and prenatal vitamin D and omega-## fatty acid supplementation supposedly operate to alter asthma risk.

  • Cancer
  • Hepatitis
  • Sweden
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited
  • Antibody therapeutics in late-stage clinical studies for non-cancer indications.

Top ## players hold majority of stake in the market ##.

  • Cancer
  • World
  • Market Size
  • Baxter International Inc.
  • Gilead Sciences, Inc.
  • NOVARTIS - QVM149
  • NOVARTIS - FEVIPIPRANT

This report covers market opportunities based on pipeline developments for six key therapeutic specialities: Alzheimer's Disease Asthma Breast Cancer Leukemia Lung Cancer Lymphoma These six areas are expected to show the strongest pipeline impact and candidates are likely to replace current therapies. The...

  • Cancer
  • AstraZeneca PLC
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

There is only about one case per million per year.

  • Cancer
  • Incyte Corporation
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group

" Our understanding of why kids get asthma is becoming clearer.

  • Cancer
  • Healthcare
  • Therapy
  • Australia
  • Social Conditions

Gilead Sciences Disrupts HCV Market Figure ##-##: Gilead Sciences Dominates HCV Market, Displaces Current Therapies ($ millions) Bristol-Myers Squibb - Opdivo Disrupts Monoclonal Antibody Performance in Cancer Figure ##-##: Monoclonal Antibodies in Cancer Treatment, Opdivo

  • Cancer
  • Leukemia
  • Oncology
  • World
  • Market Size

Particularly PDE-## and PDL-## inhibitors, the market is huge.

  • Cancer
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Australia
  • Agilent Technologies, Inc.

Drug Analysis: Masitinib Product Profiles masitinib : Prostate cancer masitinib : Colorectal cancer (CRC) masitinib : Asthma masitinib : Pancreatic cancer LIST OF FIGURES Figure ##: Masitinib for prostate cancer – SWOT analysis Figure ##: Datamonitor Healthcare’s drug assessment sum

  • Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • European Union
  • United States

Drug Overview: Masitinib TABLE OF CONTENTS ## Product Profiles## masitinib : Prostate cancer ## masitinib : Colorectal cancer (CRC) ## masitinib : Asthma ## masitinib : Pancreatic cancer LIST OF FIGURES ## Figure ##: Masitinib for prostate cancer – SWOT analysis ## Figure ##: Datamon

  • Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • European Union
  • United States

You can easily book an appointment with one online.

  • Cancer
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • MDxHealth SA
  • OPKO Health, Inc.

ATOPY, OR ALLERGY, IS INDICATED BY A PERSONAL AND SOMETIMES FAMILY HISTORY OF ASTHMA, ALLERGIC RHINITIS, OR THE MOST COMMONLY SEEN MANIFESTATION, ECZEMATOUS DERMATITIS.

  • Cancer
  • World
  • Market Size
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.
  • 4 NUCLEAR MEDICINE GLOBAL MARKET, BY MODALITY

Tc-##mhexamethyl propylene amine oxime (HMPAO) SPECT/ CT lung scans are used for asthma patients in studying the pathophysiological functions of lungs.

  • Cancer
  • World
  • Market Size
  • Cardinal Health, Inc.
  • Lantheus Medical Imaging, Inc.

For example, asthma is caused by the smooth muscle cells that line the airways squeezing more than normal.

  • Cancer
  • Cell Therapy
  • HIV AIDS
  • Therapy
  • United States
  • 8.1 REFERENCES

PLoS One; ##(##): e## Kotsopoulos J, et al. (2010).

  • Cancer
  • World
  • AbbVie Inc.
  • Aduro BioTech, Inc.
  • Amgen Inc.

ONE; ##(##): ##-##.

  • Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

Other Companies ##.

  • Cancer
  • Demand
  • Forecast
  • Market Size
  • bioCSL Inc.

The auto exports exceeded over ## million each year.

  • Cancer
  • China
  • AstraZeneca Pharmaceutical Co., Ltd
  • Bristol-Myers Squibb Company
  • Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.

They produce medicines that treat six major disease areas ---- asthma, virus control, infections, mental health, diabetes and digestive conditions.

  • Cancer
  • China
  • Demand
  • Supply
  • Novartis AG
  • PIPELINE PORTFOLIO

AMONG THESE, COPD AND ASTHMA ARE THE MOST PREVALENT WORLDWIDE.

  • Cancer
  • World
  • Market Size
  • AbbVie Inc.
  • Amgen Inc.
  • Pipeline portfolio

Opdivo Binds to PD-## on T and NKT cells.

  • Cancer
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.

The following section examines trends in co-development and licensing strategic consolidations in the market for asthma between 2006 and 2017.

  • Cancer
  • World
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.

GSK produces medicines that treat six major disease areas----asthma, virus control, infections, mental health, diabetes and digestive conditions.

  • Cancer
  • China
  • Hubei HONCH Pharmaceutical Co., Ltd.
  • Jiangsu Hansoh Pharmaceutical Co., Ltd
  • Ltd Shanghai Richem International Co.

Risks of serious side effects, including asthma, appendicitis and autoimmune diseases have been reported, as have allergic reactions to specific antigens, although these have been rare.

  • Cancer
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.

ABOUT ## IN ##, ## PEOPLE WHO GET MEASLES WILL DIE.

  • Cancer
  • World
  • GlaxoSmithKline plc
  • Meningococcal group
  • Pfizer Inc.
  • Molecule name Molecule type
  • IMMUNOTHERAPEUTICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014

Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the suppression of the immune response is called suppression immunotherapy. The global immunotherapeutics market is divided based on the segments,...

  • Cancer
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company

GSK produces medicines that treat six major disease areas----asthma, virus control, infections, mental health, diabetes and digestive conditions.

  • Cancer
  • China
  • Eli Lilly & Co.
  • Hubei HONCH Pharmaceutical Co., Ltd.
  • Jiangsu Hansoh Pharmaceutical Co., Ltd
  • 7.3. FORECAST METHODOLOGY
  • depicts the distribution of the pipeline by the type of therapy. Nearly 80% of the

THE DRUG IS CURRENTLY BEING DEVELOPED IN PHASE III FOR ASTHMA AND COPD.

  • Cancer
  • North America
  • United States
  • MedImmune, LLC
  • Roche Group